• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / Open Versus Laparoscopic Liver Resection for T1 and T2 Hepatocellular Carcinoma: A Midterm Result

Open Versus Laparoscopic Liver Resection for T1 and T2 Hepatocellular Carcinoma: A Midterm Result

Choon Hyuck D Kwon, MD PhD, Sanghyun Song, MD, Jae-won Joh, MD PhD. Samsung Medical Center, Sungkyunkwan University School of Medicine

 

Introduction: Laparoscopic liver resection (LLR) has gained much popularity in the recent years, and hepatocellular carcinoma (HCC) has increasingly become an indication for LLR. However due to the technical difficulties faced with underlying liver cirrhosis and the fear for increased recurrence, it is performed relatively restrictively. We herein present the midterm results of LLR in HCC performed in our institution and compared its results with those of open resection (OR).
Method: Retrospective analyses of 232 patients with T1 or T2 HCC that receive liver resection (OR 261, LLR 71) from January 2008 until February 2011 were analyzed. Indication for LLR was tumor size less than 5cm except in peripheral protruding masses, and restricted to tumors located at anterolateral segments including both segments 4a and 4b and segment 1. Preclinical data, disease free survival and patient survival was analyzed according to T stage.
Results: More female patients received LLR (25.4% vs. 14.3%, p=0.042). There were more T2 patients in OR (60.9% vs. 36.6%, p=0.001) but background cirrhosis was more frequent in LLR (56.3% vs. 41.6%, p=0.038). In subgroup analysis of T1 (OR 63, LLR 45), estimated blood loss, transfusion rate, preop PIVKA-II, preop WBC was higher, admission days and op time longer and tumor size larger in OR group (p<0.05), but preop AFP, tumor grade, and ICG15min, and safety resection margin was not different. Recurrence free survival (OR 78.5% vs. LLR 80.4%, p=0.67) and patient survival (98.2% vs. 100%, p=0.38) at 3 years were not different. In T2 analysis, OR group had larger tumor size, higher preop AFP and PIVKA-II and longer op time (p<0.05), but the estimated blood loss, transfusion rate, tumor grade, ICG15min and resection margin was not different. Recurrence free survival (OR 64.6% vs. LLR 59.5%, p=0.98) and patient survival (96.3% vs. 83.4%, p=0.13) at 3 years were not different.
Conclusion: Laparoscopic liver resection in HCC with T1 or T2 stage seems to be feasible with equal midterm survival compared to open resection.

Figure: Overall patients survival and recurrence free survival of OR(n=161) and LLR(n=71) does not differ between groups (p=0.60 and 0.39 respectively). The percentage shows the 3 year survival rate.

  Recurrence free survival


Session Number: PDIST – Posters of Distinction
Program Number: P011
View Poster

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search